A Comparison of Bacteremic Pneumococcal Pneumonia with Nonbacteremic Community-Acquired Pneumonia of Any Etiology — Results from a Canadian Multicenter Study by Thomas J Marrie, Donald E Low, Emidio de Carolis, the Canadian Community-Acquired Pneumonia Investigators

Get full text

An Assessment of Linezolid Utilization in Selected Canadian Provinces by Sandra Walker, Linda Dresser, Debbie Becker, Alissa Scalera

Get full text

Pathological effects of pregabalin toxicity in rats by Roaa Salih Mahdi, Nawras Najah, Sura Salman Ejam

“…The dosage was determined using the maximum lethal oral dose in rats (5000 mg/kg) (Pfizer, 2017). Based on the rats’ weights, a toxic dosage of 1000 mg of PGB was determined and reconstituted in normal saline (0.9% in 3 mL). …”
Get full text

A Retrospective Claims Data Analysis on the Burden of COVID-19-Related Hospitalization in Adults at High Risk for Severe Disease Progression in Germany by Timotheus Stremel, Svitlana Schnaidt, Nicole Bihrer, Emma Fröling, Christian Jacob, Agnes Kisser

Get full text

Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensus by Georgia Kourlaba, Michail Vikelis, Theodoros Karapanayiotides, Argyro Solakidi, Dimitrios Trafalis, Katerina Lioliou, Panagiotis Andriopoulos, Aspasia Panagiotou, Dimos-Dimitrios Mitsikostas

Get full text

Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant by Sophie Marbaix, Sophie Marbaix, Steven Simoens, Philippe Clevenbergh, Pascal Van Bleyenbergh, Keliane Liberman, Dimitri Dehenau

Get full text

Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis by Katharina Schley, Kirstin Heinrich, Jennifer C. Moïsi, Dennis Häckl, Dominik Obermüller, Gordon Brestrich, Christof von Eiff, Thomas Weinke

Get full text

Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study by David Kudrow, Susan Hutchinson, Glenn C. Pixton, Terence Fullerton

Get full text

An Economic Evaluation of Voriconazole versus Amphotericin B for the Treatment of Invasive Aspergillosis in Canada by Coleman Rotstein, Michel Laverdière, Anne Marciniak, Farzad Ali

Get full text

Assessing the Subjective and Physiological Effects of Intranasally Administered Crushed Extended-Release Morphine Formulations with and without a Sequestered Naltrexone Core in Rec... by Beatrice Setnik, Veeraindar Goli, Naama Levy-Cooperman, Catherine Mills, Megan Shram, Ira Smith

Get full text

Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: a phase IV s... by Muhit Özcan, Ryan D. Cassaday, Ewa Zarzycka, Erik Vandendries, Fan Zhang, Ying Chen, Alejandra Nieto, Fatih Demirkan, Pau Montesinos, Fevzi Altuntas

Get full text

Description and characterization of pneumococcal community acquired pneumonia (CAP) among radiologically confirmed CAP in outpatients by Josselin Le Bel, Juliette Pinot, Toni Alfaiate, Marie Ecollan, Fanny Cussac, Raphaël Pecqueur, Marie-Pierre Revel, Cyrille Vartanian, Emmanuelle Varon, Christian Theilacker, Xavier Duval, Henri Partouche, Cédric Laouénan, Serge Gilberg

“…Pneumococcal CAP was defined by the combination of a chest X-ray (CXR) compatible with CAP and SP detection by any of four microbiological tests (blood culture, sputum culture, pneumococcal urinary antigen test [BinaxNow®] and serotype-specific multiplex urinary antigen detection test [Pfizer Inc®]. To identify other pathogens, next to cultures, nasopharyngeal multiplex PCR was performed. …”
Get full text

Epidemiology of clinically significant migraine in Israel: a retrospective database study by A. Shifrin, E. Domany, M. Tirosh, D. Davidovici, S. Vinker, I. Forschner, A. Israel

Get full text

Comparison of Newly Diagnosed Ocular Hypertension and Open-Angle Glaucoma: Ocular Variables, Risk Factors, and Disease Severity by Yvonne M. Buys, Paul Harasymowycz, Rania Gaspo, Kenneth Kwok, Cindy M. L. Hutnik, Pierre Blondeau, Catherine M. Birt, Robert L. G. Piemontesi, Lisa F. Gould, Mark R. Lesk, Iqbal K. Ahmed

Get full text

Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches by Mingyue Li, Victor A. Beaumont, Shahajahan Akbar, Hannah Duncan, Arch Creasy, Wenge Wang, Kelly Sackett, Lisa Marzilli, Jason C. Rouse, Hai-Young Kim

Get full text

Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets—A Focus on the JAK-STAT Pathway by Fausto Salaffi, Giovanni Giacobazzi, Marco Di Carlo

Get full text

Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in Quebec by Martine Pettigrew, Daniel JG Thirion, Michael Libman, Giovanni Zanotti

Get full text

BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura by A. K. Ghosh, S. Bhushan, L. D. R. Lopez, D. Sampat, Z. Salah, C. A. Hatoum

“…Herein, we present a patient who presented with severe ITP with a platelet count of 0 after receiving the second dose of the BNT162b2 mRNA COVID-19 vaccine (also known as the Pfizer BioNTech). She subsequently recovered with a prolonged treatment course.…”
Get full text

Análisis de la búsqueda sobre vacunas contra la COVID-19 en países sudamericanos by Yuly R. Santos-Rosales, Bellanira S. Aliaga-Cáceres, Edson J. Tovar-Yaro, Martha Bernuy-Portilla, Verónica I. Huanca-Mamani, Jose Armada, Christian R. Mejia

“…Se comparó el uso de 6 términos ("Vacuna contra COVID-19", "Efectividad vacunas contra COVID-19", "vacuna Pfizer", "vacuna Sinopharm", "efectos secundarios de la vacuna Pfizer", "efectos secundarios de la vacuna Sinopharm") en 9 países sudamericanos de habla hispana. …”
Get full text

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]) by A. DeMichele, A. C. Dueck, D. Hlauschek, M. Martin, H. Burstein, G. Pfeiler, N. Zdenkowski, A. Wolff, M. Bellet-Ezquerra, E. Winer, M. Balic, K. Miller, M. Colleoni, D. Lake, G. Rubovsky, D. Cameron, J. Balko, C. F. Singer, Z. Nowecki, H. Iwata, N. Wolmark, K. A. Parraga, H. Rugo, G. G. Steger, T. Traina, G. Werutsky, D. Czajkowska, O. Metzger, S. El-Abed, K. P. Theall, R. D. Lu, P. O’Brien, C. Fesl, E. Mayer, M. Gnant

“…Methods PALLAS was an international, multicenter, randomized, open-label, phase III trial, representing a public–private partnership between Pfizer, the Austrian Breast Cancer Study Group, and the U.S. …”
Get full text